 |
|
|
| |
Tenofovir prophylaxis during pregnancy for the elimination
of mother-to-child transmission of hepatitis B virus: A cost-effectiveness analysis
|
| |
| |
Of 223 infants enrolled, 212(95.0%) received HBIG while 11(5.0%) did not. None (0%, 95%CI = [0, 1.69]) of the infants had chronic HBV infection.
We retrospectively reviewed medical records of mother and infant pairs whose mothers have HBeAg-positive and received TDF in preventing maternal to child transmission of viral hepatitis B according to Thai national guidelines during 2018-2020.
EASL 2023 june 21-24 vienna
|
| |
|
|
|
|
|
